Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Atai Life Sciences B.v. (ATAI)  
$2.19 0.01 (0.45%) as of 4:30 Mon 6/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 152,570,000
Market Cap: 334.13(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.06 - $2.55
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    : 21.1
Insider 3/6 Months : 21.7
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   ATAI Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. info@atai.life


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 12,635,718 12,635,718 12,695,718
Total Buy Value $0 $25,275,008 $25,275,008 $25,356,096
Total People Bought 0 1 1 2
Total Buy Transactions 0 2 2 4
Total Shares Sold 0 182,250 182,250 458,404
Total Sell Value $0 $246,037 $246,037 $767,514
Total People Sold 0 5 5 6
Total Sell Transactions 0 5 5 9
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 54
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Angermayer Christian   –       •       •   2025-03-24 4 B $1.40 $2,520,000 I/I 1,800,000 42,369,415 0.01 40%     
   Short Glenn Frank Chief Scientific Officer   •       •      –    2025-03-21 4 S $1.35 $17,767 D/D (13,161) 42,333 -52%     
   Rao Srinivas See Remarks   •       •      –    2025-03-21 4 S $1.35 $101,814 D/D (75,418) 212,942 -52%     
   Kirpekar Sahil Chief Business Officer   •       •      –    2025-03-21 4 S $1.35 $65,560 D/D (48,563) 115,636 -52%     
   Craig Kevin James Chief Medical Officer   •       •      –    2025-03-21 4 S $1.35 $15,610 D/D (11,563) 8,437 -52%     
   Johnson Anne Nagengast Chief Financial Officer   •       •      –    2025-03-21 4 S $1.35 $45,286 D/D (33,545) 140,045 -52%     
   Rao Srinivas See Remarks   •       •      –    2025-03-14 4 OE $0.00 $0 D/D 175,000 288,360     -
   Johnson Anne Nagengast Chief Financial Officer   •       •      –    2025-03-14 4 OE $0.00 $0 D/D 100,000 173,590     -
   Kirpekar Sahil Chief Business Officer   •       •      –    2025-03-14 4 OE $0.00 $0 D/D 100,000 164,199     -
   Short Glenn Frank Chief Scientific Officer   •       •      –    2025-03-14 4 OE $0.00 $0 D/D 32,500 55,494     -
   Craig Kevin James Chief Medical Officer   •       •      –    2025-03-14 4 OE $0.00 $0 D/D 20,000 20,000     -
   Angermayer Christian   –       •       •   2025-02-14 4 B $2.10 $22,755,008 I/I 10,835,718 40,555,215 0.01 -2%     
   Short Glenn Frank Chief Scientific Officer   •       –      –    2025-01-01 3 IO $0.00 $0 D/D 0 22,994 -11%     
   Brand Florian See Remarks   •       •      –    2024-05-16 4 S $1.92 $290,502 D/D (151,303) 328,697 36%     
   Johnson Anne Nagengast Chief Financial Officer   •       •      –    2024-04-02 4 S $1.85 $50,709 D/D (27,410) 73,590 35%     
   Rao Srinivas See Remarks   •       •      –    2024-04-02 4 S $1.85 $114,034 D/D (61,640) 113,360 35%     
   Kirpekar Sahil Chief Business Officer   •       •      –    2024-04-02 4 S $1.85 $66,232 D/D (35,801) 64,199 35%     
   Johnson Anne Nagengast Chief Financial Officer   •       •      –    2024-03-14 4 OE $0.00 $0 D/D 100,000 101,000     -
   Rao Srinivas See Remarks   •       •      –    2024-03-14 4 OE $0.00 $0 D/D 175,000 175,000     -
   Brand Florian See Remarks   •       •      –    2024-03-14 4 OE $0.00 $0 D/D 350,000 480,000     -
   Kirpekar Sahil Chief Business Officer   •       •      –    2024-03-14 4 OE $0.00 $0 D/D 100,000 100,000     -
   Brand Florian See Remarks   •       •      –    2023-11-16 4 B $1.16 $23,120 D/D 20,000 130,000 0.01 77%     
   Brand Florian See Remarks   •       –      –    2023-09-13 4 B $1.45 $57,968 D/D 40,000 110,000 0.01 30%     
   Brand Florian See Remarks   •       –      –    2023-03-29 4 B $1.48 $103,558 D/D 70,000 70,000 2.74 10%     
   Angermayer Christian 10% Owner   –       –       •   2023-03-29 4 B $1.32 $1,600,443 I/I 1,214,297 32,086,697 1.5 10%     

  54 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed